Quality indicators for the management of endometrial, cervical and ovarian cancer

被引:18
|
作者
Bonte, Anne-Sophie [1 ,2 ]
Luyckx, Annemie [1 ,2 ]
Wyckmans, Leen [1 ,2 ]
Trinh, Xuan Bich [1 ,2 ]
van Dam, Peter A. [1 ,2 ]
机构
[1] Antwerp Univ Hosp, MOCA, B-2650 Edegem, Belgium
[2] Univ Antwerp, Ctr Oncol Res CORE, B-2610 Antwerp, Belgium
来源
EJSO | 2019年 / 45卷 / 04期
关键词
Quality indicators; Guidelines; Endometrial cancer; Cervical cancer; Ovarian cancer; OF-CARE; RADICAL HYSTERECTOMY; LYMPH-NODES; SURVIVAL; THERAPY; BRACHYTHERAPY; SURGERY; IMPACT; ASSOCIATION; GUIDELINES;
D O I
10.1016/j.ejso.2018.10.051
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Measuring quality indicators improves the quality of care. The aim of this review is to identify a set of quality indicators (QIs) that can be used to measure the standard of treatment for patients with endometrial, cervical and ovarian cancer. Methods: A systematic literature search was performed in the Pubmed and Google Scholar database. Articles related to the field of interest, which covered QIs for the management of endometrial, cervical and ovarian cancer, were included if they were written in English and available in full text. Articles related to prevention, screening, diagnosis, quality of life and patient satisfaction were excluded. Results: A total of 57 suitable articles was found: 13 for endometrial cancer, 17 for cervical cancer and 27 for ovarian cancer. An overview of the selected QIs was made and classified by type of indicator. Relevant QIs related to the structural organisation of health care are: referral to high volume specialists in high volume hospitals, treatment by specialized gynecological oncologists and discussion of treatment plan by a multi-disciplinary team according to current guidelines. Important process measures are: a patient report of high quality, an adequate pretreatment staging and an adherence to treatment guidelines. The ultimate goal is to reduce treatment related morbidity and increase the survival rate, which can be measured as outcome indicators. Conclusion: The proposed set of QIs should be validated and can be implemented into quality assurance programmes to improve the quality of care and the outcome of patients with a gynecological cancer. (C) 2018 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
引用
收藏
页码:528 / 537
页数:10
相关论文
共 50 条
  • [1] Acceptability of quality indicators for the management of endometrial, cervical and ovarian cancer: results of an online survey
    Annemie Luyckx
    Leen Wyckmans
    Anne-Sophie Bonte
    Xuan Bich Trinh
    Peter A. van Dam
    [J]. BMC Women's Health, 20
  • [2] Acceptability of quality indicators for the management of endometrial, cervical and ovarian cancer: results of an online survey
    Luyckx, Annemie
    Wyckmans, Leen
    Bonte, Anne-Sophie
    Trinh, Xuan Bich
    van Dam, Peter A.
    [J]. BMC WOMENS HEALTH, 2020, 20 (01)
  • [3] EVALUATION AND SELECTION OF QUALITY INDICATORS FOR THE MANAGEMENT OF ENDOMETRIAL CANCER
    Koskas, M.
    Chenoz, L.
    Phelippeau, J.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 214 - 214
  • [4] EVALUATION AND SELECTION OF QUALITY INDICATORS FOR THE MANAGEMENT OF ENDOMETRIAL CANCER
    Koskas, M.
    Chenoz, L.
    Phelippeau, J.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1118 - 1118
  • [5] Evaluation and Selection of Quality Indicators for the Management of Endometrial Cancer
    Chenoz, Laure
    Phelippeau, Juliette
    Barranger, Emmanuel
    Bourdel, Nicolas
    Brun, Jean Luc
    Chereau, Elisabeth
    Collinet, Pierre
    Coutant, Charles
    Darai, Emile
    Deffieux, Xavier
    Gautier, Tristan
    Golfier, Francois
    Huchon, Cyrille
    Ouldamer, Lobna
    Rouzier, Roman
    Koskas, Martin
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (05) : 979 - 986
  • [6] Ovarian, cervical and endometrial cancer
    Rousseau, C.
    Salaun, P. Y.
    [J]. MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2019, 43 (01): : 104 - 124
  • [7] Serum tumor markers in the management of ovarian, endometrial and cervical cancer
    Gadducci, A
    Cosio, S
    Carpi, A
    Nicolini, A
    Genazzani, AR
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (01) : 24 - 38
  • [8] QUALITY INDICATORS (QIs) IN ADVANCED OVARIAN CANCER (AOC) MANAGEMENT
    Tripodi, E.
    Fuso, L.
    Daniela, A.
    Villa, M.
    Zanfagnin, V.
    Menato, G.
    Ferrero, A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 846 - 846
  • [9] Surgical therapeutic management for the preservation of fertility in patients with cervical, endometrial, and ovarian cancer
    Villatoro, A. Redondo
    Lopez, M. Moreno
    Garrido, M. Pantoja
    [J]. CLINICA E INVESTIGACION EN GINECOLOGIA Y OBSTETRICIA, 2021, 48 (03):
  • [10] Management of endometrial, ovarian and cervical cancer in the elderly: current approach to a challenging condition
    Salvatore Giovanni Vitale
    Stella Capriglione
    Gabriella Zito
    Salvatore Lopez
    Ferdinando Antonio Gulino
    Federica Di Guardo
    Amerigo Vitagliano
    Marco Noventa
    Valentina Lucia La Rosa
    Fabrizio Sapia
    Gaetano Valenti
    Agnese Maria Chiara Rapisarda
    Isabel Peterlunger
    Diego Rossetti
    Antonio Simone Laganà
    [J]. Archives of Gynecology and Obstetrics, 2019, 299 : 299 - 315